Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 43651-43700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06485557
A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
PHASE3Not yet recruiting
90 participants
Started: Aug 1, 2024 · Completed: Aug 1, 2026
1 condition1 sponsor0 locations
NCT06538883
Sedation in ICU Patients With Mechanical Ventilation
NANot yet recruiting
366 participants
Started: Aug 1, 2024 · Completed: Jul 30, 2026
2 conditions32 sponsors0 locations
NCT06515977
Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions
NANot yet recruiting
2,964 participants
Started: Aug 1, 2024 · Completed: Aug 1, 2025
2 conditions23 sponsors0 locations
NCT06534645
STOP-stroke: STroke Outcome Prediction in the Acute Treatment Setting
N/ANot yet recruiting
250 participants
Started: Aug 1, 2024 · Completed: Jul 30, 2027
1 condition1 sponsor0 locations
NCT06525870
Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial
PHASE2Enrolling by invitation
44 participants
Started: Aug 1, 2024 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT06492070
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
PHASE2Recruiting
70 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2027
7 conditions2 sponsors3 locations
NCT06501417
EC_ItaLynch: Mainstreaming the Diagnosis of Lynch Syndrome
N/ANot yet recruiting
600 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT07067723
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)
N/AEnrolling by invitation
122 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06545084
Evaluation of Periapical Healing Following Endodontic Microsurgery With Leukocyte and Platelet Rich Fibrin (L-PRF)
N/ARecruiting
50 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06362239
Prospective Home-Based Palliative Care and Hospice Study
N/AEnrolling by invitation
250 participants
Started: Aug 1, 2024 · Completed: Oct 31, 2027
1 condition5 sponsors1 location
NCT06880198
Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma
NARecruiting
20 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06555640
A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
PHASE2Recruiting
72 participants
Started: Aug 1, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06501664
Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
PHASE3Not yet recruiting
360 participants
Started: Aug 1, 2024 · Completed: Nov 30, 2027
1 condition1 sponsor0 locations
NCT06530433
Enhanced Community First Responder System Evaluation in Singapore
NAEnrolling by invitation
165 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06540469
Iodine Supplementation in Graves' Hyperthyroidism
NANot yet recruiting
315 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2028
2 conditions3 sponsors0 locations
NCT07139600
Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy
N/AActive, not recruiting
5 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2027
3 conditions1 sponsor1 location
NCT06472323
The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia
N/ARecruiting
270 participants
Started: Aug 1, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06709027
The Construction and Application of a Mobile Health Management Program for Elderly Depression Based on the Patterns of Cognitive Function Changes
NAEnrolling by invitation
80 participants
Started: Aug 1, 2024 · Completed: Jan 10, 2025
1 condition1 sponsor1 location
NCT06641505
Feasibility of Deep Inspiratory Internal Jugular Vein Variability in Guiding Preoperative Fluid Replacement
NARecruiting
80 participants
Started: Aug 1, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06543758
Effectiveness and Safety of At-home Gait Rehabilitation Using Wearable Exoskeletal Robot
PHASE4Recruiting
16 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT06288009
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
NARecruiting
50 participants
Started: Aug 1, 2024 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT06502925
Quality of Incoming Call Handling in an Emergency Dispatch Center
N/ARecruiting
800 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor2 locations
NCT06707129
Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
N/ARecruiting
50 participants
Started: Aug 1, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06570811
Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients
PHASE2Recruiting
40 participants
Started: Aug 1, 2024 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT06546527
Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer(mCRPC)
EARLY_PHASE1Not yet recruiting
12 participants
Started: Aug 1, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor0 locations
NCT05553236
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
NARecruiting
2,500 participants
Started: Aug 1, 2024 · Completed: Jan 31, 2027
3 conditions8 sponsors1 location
NCT06608732
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
PHASE2Recruiting
20 participants
Started: Aug 1, 2024 · Completed: Jul 1, 2028
1 condition2 sponsors1 location
NCT07061301
Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus
NARecruiting
80 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2026
5 conditions1 sponsor1 location
NCT06637007
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
PHASE2Recruiting
30 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT06500663
Studying Thyroid Function of Haemodialysis Patients in Upper Egypt (Two Centers Study).
N/ANot yet recruiting
160 participants
Started: Aug 1, 2024 · Completed: Dec 30, 2026
1 condition2 sponsors0 locations
NCT06540781
The Efficacy of Wet Cupping Therapy on Cerebral Oxygenation
NARecruiting
40 participants
Started: Aug 1, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06799923
Possibilities of Use MRI-Guided Laser Interstitial Thermal Therapy in Medically Intractable Tremor
NARecruiting
15 participants
Started: Aug 1, 2024 · Completed: Apr 30, 2026
5 conditions4 sponsors1 location
NCT06988098
The Effect of Different Deproteinising Agents on the Clinical Success of Fissure Sealants in Permanent Teeth
NARecruiting
60 participants
Started: Aug 1, 2024 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT06707532
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
NARecruiting
32 participants
Started: Aug 1, 2024 · Completed: Dec 1, 2025
7 conditions1 sponsor1 location
NCT06416982
Perineal Massage for Pessary Examinations
NARecruiting
68 participants
Started: Aug 1, 2024 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT06439927
New Method to Close Nasal Septal Perforation
NARecruiting
23 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06493006
Promoting Sustainable and Active Mobility Among Employees and Students
N/ARecruiting
500 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT06399107
Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease
PHASE1/PHASE2Recruiting
85 participants
Started: Aug 1, 2024 · Completed: Dec 28, 2025
2 conditions1 sponsor1 location
NCT06492395
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
PHASE3Recruiting
178 participants
Started: Aug 1, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06528080
Clinical Study of LY-M001 Injection in the Treatment of Adolescents With Type I Gaucher Disease
EARLY_PHASE1Recruiting
9 participants
Started: Aug 1, 2024 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT06515587
Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
NARecruiting
40 participants
Started: Aug 1, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06898528
A Novel Mat Exercise Program Improves Functional Fitness, Activity Levels, and Quality of Life in Older Adults
NAActive, not recruiting
32 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06417151
Polish Infants and Toddler Nutritional Study
N/AEnrolling by invitation
1,000 participants
Started: Aug 1, 2024 · Completed: Nov 30, 2024
11 conditions2 sponsors1 location
NCT06689176
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
NARecruiting
40 participants
Started: Aug 1, 2024 · Completed: Aug 1, 2025
2 conditions2 sponsors1 location
NCT06695884
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
NARecruiting
42 participants
Started: Aug 1, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06688305
68Ga-NI-FAPI PET/CT: First-in-human Study
EARLY_PHASE1Recruiting
40 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06533384
PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
PHASE3Recruiting
310 participants
Started: Aug 1, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06796166
The Impact of AI- Supported Education in Mastectomy Patient
NARecruiting
40 participants
Started: Aug 1, 2024 · Completed: Aug 1, 2025
5 conditions2 sponsors1 location
NCT06839443
Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy
N/ARecruiting
100 participants
Started: Aug 1, 2024 · Completed: Jun 20, 2025
1 condition1 sponsor1 location
NCT06468306
Combined Molecular and Mechanistic Methods for Detection of Pressure Ulcers
N/ANot yet recruiting
150 participants
Started: Aug 1, 2024 · Completed: Dec 30, 2027
2 conditions2 sponsors1 location